INS and kidney disorder: Therefore, we conducted this retrospective study to analyze the insulin dose characteristics of T2DKD patients undergoing short-term CSII therapy in different stages of renal disease and to analyze the impact of combined oral hypoglycemic drugs on insulin dosage during CSII therapy.